Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC) (Impact AFP)

Clinical Trial ID NCT03156582

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03156582

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology 2012 2.01
2 Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 2006 1.86
3 Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients. World J Gastroenterol 2006 1.58
4 Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 2005 1.28
5 Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma. Liver Int 2011 0.81
Next 100